Immediate Termination of Study by Institution Sample Clauses
The Immediate Termination of Study by Institution clause grants the institution the right to end a research study without prior notice under certain circumstances. Typically, this clause applies if there are concerns about participant safety, regulatory compliance, or other significant issues that make continuation of the study untenable. Its core function is to protect the institution and study participants by allowing swift action in response to unforeseen risks or violations, thereby ensuring ethical and legal standards are maintained.
Immediate Termination of Study by Institution. Institution may terminate the Study immediately upon notification to CRO if requested to do so by the responsible SUKL/IEC or if such termination is required to protect the health of Study Subjects.
Immediate Termination of Study by Institution. Institution, reserves the right to terminate the Study immediately upon notification to Sponsor if requested to do so by the competent IEC or Competent Authority or if such termination is required to protect the safety of Study Subject.
Immediate Termination of Study by Institution. Institution may
Immediate Termination of Study by Institution. Institution will have the right to terminate a Study immediately upon notification to Pfizer: (i) if the Principal Investigator at Institution for such Study is no longer affiliated with the Institution or is no longer able to perform the duties required of Principal Investigator and the Institution is unable to identify a replacement Principal Investigator acceptable to Pfizer, (ii) if requested to do so by the responsible IRB or for regulatory reasons, or (iii) for considerations of the health, welfare, or safety of the Study subjects, which considerations in the reasonable and good faith opinion of Principal Investigator or Institution support immediate termination of the Study.